Your browser doesn't support javascript.
loading
Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.
Tran, Gia-Buu; Ding, Jane; Ye, Bingwei; Liu, Mengling; Yu, Yajie; Zha, Yunhong; Dong, Zheng; Liu, Kebin; Sudarshan, Sunil; Ding, Han-Fei.
Afiliación
  • Tran GB; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Ding J; O'Neal Comprehensive Cancer Center, Birmingham, Alabama.
  • Ye B; Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City, Vietnam.
  • Liu M; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Yu Y; O'Neal Comprehensive Cancer Center, Birmingham, Alabama.
  • Zha Y; Georgia Prevention Institute, Augusta University, Augusta, Georgia.
  • Dong Z; Institute of Neural Regeneration and Repair and Department of Neurology, The First Hospital of Yichang, Three Gorges University College of Medicine, Yichang, China.
  • Liu K; Institute of Neural Regeneration and Repair and Department of Neurology, The First Hospital of Yichang, Three Gorges University College of Medicine, Yichang, China.
  • Sudarshan S; Institute of Neural Regeneration and Repair and Department of Neurology, The First Hospital of Yichang, Three Gorges University College of Medicine, Yichang, China.
  • Ding HF; Department of Cell Biology and Anatomy, Augusta University, Augusta, Georgia.
Cancer Res ; 83(13): 2248-2261, 2023 07 05.
Article en En | MEDLINE | ID: mdl-37057874

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2023 Tipo del documento: Article